메뉴 건너뛰기




Volumn 89, Issue 3, 2014, Pages 148-161

Medical management of first-trimester abortion

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; IBUPROFEN; LETROZOLE; METHOTREXATE; MIFEPRISTONE; MISOPROSTOL; TAMOXIFEN;

EID: 84896523068     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2014.01.016     Document Type: Article
Times cited : (43)

References (112)
  • 1
    • 84873126269 scopus 로고    scopus 로고
    • Abortion surveillance-United States, 2009. Centers for Disease Control and Prevention (CDC)
    • (Level II-3)
    • K. Pazol, A.A. Creanga, S.B. Zane, K.D. Burley, and D.J. Jamieson Abortion surveillance-United States, 2009. Centers for Disease Control and Prevention (CDC) MMWR Surveill Summ 61 SS-8 2012 1 44 (Level II-3)
    • (2012) MMWR Surveill Summ , vol.61 , Issue.SS-8 , pp. 1-44
    • Pazol, K.1    Creanga, A.A.2    Zane, S.B.3    Burley, K.D.4    Jamieson, D.J.5
  • 2
    • 0021931574 scopus 로고
    • Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women
    • A. Gravanis, G. Schaison, M. George, J. de Brux, P.G. Satyaswaroop, and E.E. Baulieu et al. Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women J Clin Endocrinol Metab 60 1985 156 163 (Level III) (Pubitemid 15194664)
    • (1985) Journal of Clinical Endocrinology and Metabolism , vol.60 , Issue.1 , pp. 156-163
    • Gravanis, A.1    Schaison, G.2    George, M.3
  • 3
    • 0023705738 scopus 로고
    • The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin
    • (Level II-3)
    • M.L. Swahn, and M. Bygdeman The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin Br J Obstet Gynaecol 95 1988 126 134 (Level II-3)
    • (1988) Br J Obstet Gynaecol , vol.95 , pp. 126-134
    • Swahn, M.L.1    Bygdeman, M.2
  • 4
    • 0024545715 scopus 로고
    • Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486
    • DOI 10.1016/0010-7824(89)90019-X
    • E. Johannisson, M. Oberholzer, M.L. Swahn, and M. Bygdeman Vascular changes in the human endometrium following the administration of the progesterone antagonist RU 486 Contraception 39 1989 103 117 (Level III) (Pubitemid 19022942)
    • (1989) Contraception , vol.39 , Issue.1 , pp. 103-117
    • Johannisson, E.1    Oberholzer, M.2    Swahn, M.-L.3    Bygdeman, M.4
  • 5
    • 34147133251 scopus 로고    scopus 로고
    • Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: A randomized controlled trial
    • DOI 10.1097/01.AOG.0000258298.35143.d2, PII 0000625020070400000015
    • M.D. Creinin, C.A. Schreiber, P. Bednarek, H. Lintu, M.S. Wagner, and L.A. Meyn Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Medical Abortion at the Same Time (MAST) Study Trial Group. Obstet Gynecol 109 2007 885 894 (Level I) (Pubitemid 46559076)
    • (2007) Obstetrics and Gynecology , vol.109 , Issue.4 , pp. 885-894
    • Creinin, M.D.1    Schreiber, C.A.2    Bednarek, P.3    Lintu, H.4    Wagner, M.-S.5    Meyn, L.A.6
  • 6
    • 47249123713 scopus 로고    scopus 로고
    • Glucocorticoid receptor antagonists
    • DOI 10.2174/156802608784535011
    • R.D. Clark Glucocorticoid receptor antagonists Curr Top Med Chem 8 2008 813 838 (Level III) (Pubitemid 351982568)
    • (2008) Current Topics in Medicinal Chemistry , vol.8 , Issue.9 , pp. 813-838
    • Clark, R.D.1
  • 7
    • 77957748919 scopus 로고    scopus 로고
    • Mifepristone: Where do we come from and where are we going? Clinical development over a quarter of a century
    • (Level III)
    • I.M. Spitz Mifepristone: where do we come from and where are we going? Clinical development over a quarter of a century Contraception 82 2010 442 452 (Level III)
    • (2010) Contraception , vol.82 , pp. 442-452
    • Spitz, I.M.1
  • 8
    • 77956061420 scopus 로고    scopus 로고
    • Uses of misoprostol in obstetrics and gynecology
    • (Level III)
    • R. Allen, and B.M. O'Brien Uses of misoprostol in obstetrics and gynecology Rev Obstet Gynecol 2 2009 159 168 (Level III)
    • (2009) Rev Obstet Gynecol , vol.2 , pp. 159-168
    • Allen, R.1    O'Brien, B.M.2
  • 9
    • 0030964275 scopus 로고    scopus 로고
    • Absorption kinetics of misoprostol with oral or vaginal administration
    • DOI 10.1016/S0029-7844(97)00111-7, PII S0029784497001117
    • M. Zieman, S.K. Fong, N.L. Benowitz, D. Banskter, and P.D. Darney Absorption kinetics of misoprostol with oral or vaginal administration Obstet Gynecol 90 1997 88 92 (Level I) (Pubitemid 27272963)
    • (1997) Obstetrics and Gynecology , vol.90 , Issue.1 , pp. 88-92
    • Zieman, M.1    Fong, S.K.2    Benowitz, N.L.3    Banskter, D.4    Darney, P.D.5
  • 10
    • 0033081990 scopus 로고    scopus 로고
    • Comparison between oral and vaginal administration of misoprostol on uterine contractility
    • DOI 10.1016/S0029-7844(98)00436-0, PII S0029784498004360
    • K.G. Danielsson, L. Marions, A. Rodriguez, B.W. Spur, P.Y. Wong, and M. Bygdeman Comparison between oral and vaginal administration of misoprostol on uterine contractility Obstet Gynecol 93 1999 275 280 (Level I) (Pubitemid 29068106)
    • (1999) Obstetrics and Gynecology , vol.93 , Issue.2 , pp. 275-280
    • Danielsson, K.G.1    Marions, L.2    Rodriguez, A.3    Spur, B.W.4    Wong, P.Y.K.5    Bygdeman, M.6
  • 11
    • 0036182991 scopus 로고    scopus 로고
    • Pharmacokinetics of different routes of administration of misoprostol
    • O.S. Tang, H. Schweer, H.W. Seyberth, S.W. Lee, and P.C. Ho Pharmacokinetics of different routes of administration of misoprostol Hum Reprod 17 2002 332 336 (Level I) (Pubitemid 34168436)
    • (2002) Human Reproduction , vol.17 , Issue.2 , pp. 332-336
    • Tang, O.S.1    Schweer, H.2    Seyberth, H.W.3    Lee, S.W.H.4    Ho, P.C.5
  • 12
    • 25444491675 scopus 로고    scopus 로고
    • Comparison of misoprostol plasma concentrations following buccal and sublingual administration
    • DOI 10.1016/j.contraception.2004.06.014
    • E.A. Schaff, R. DiCenzo, and S.L. Fielding Comparison of misoprostol plasma concentrations following buccal and sublingual administration Contraception 71 2005 22 25 (Level II-3) (Pubitemid 41583143)
    • (2005) Contraception , vol.71 , Issue.1 , pp. 22-25
    • Schaff, E.A.1    DiCenzo, R.2    Fielding, S.L.3
  • 13
    • 33748360739 scopus 로고    scopus 로고
    • Misoprostol administered by epithelial routes: Drug absorption and uterine response
    • DOI 10.1097/01.AOG.0000230398.32794.9d, PII 0000625020060900000017
    • K.R. Meckstroth, A.K. Whitaker, S. Bertisch, A.B. Goldberg, and P.D. Darney Misoprostol administered by epithelial routes: drug absorption and uterine response Obstet Gynecol 108 2006 582 590 (Level I) (Pubitemid 44337099)
    • (2006) Obstetrics and Gynecology , vol.108 , Issue.3 , pp. 582-590
    • Meckstroth, K.R.1    Whitaker, A.K.2    Bertisch, S.3    Goldberg, A.B.4    Darney, P.D.5
  • 14
    • 0035988402 scopus 로고    scopus 로고
    • A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy
    • J.K. Jain, C. Dutton, B. Harwood, K.R. Meckstroth, and D.R. Mishell Jr. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy Hum Reprod 17 2002 1477 1482 (Level I) (Pubitemid 34661795)
    • (2002) Human Reproduction , vol.17 , Issue.6 , pp. 1477-1482
    • Jain, J.K.1    Dutton, C.2    Harwood, B.3    Meckstroth, K.R.4    Mishell Jr., D.R.5
  • 15
    • 84863320054 scopus 로고    scopus 로고
    • Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam
    • (Level I)
    • J. Blum, S. Raghavan, R. Dabash, N. Ngoc, H. Chelli, and S. Hajri et al. Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam Int J Gynaecol Obstet 118 2012 166 171 (Level I)
    • (2012) Int J Gynaecol Obstet , vol.118 , pp. 166-171
    • Blum, J.1    Raghavan, S.2    Dabash, R.3    Ngoc, N.4    Chelli, H.5    Hajri, S.6
  • 16
    • 33645205776 scopus 로고    scopus 로고
    • Medical abortion regimens: Historical context and overview
    • (Level III)
    • M.D. Creinin Medical abortion regimens: historical context and overview Am J Obstet Gynecol 183 2000 S3 S9 (Level III)
    • (2000) Am J Obstet Gynecol , vol.183
    • Creinin, M.D.1
  • 17
    • 0037383292 scopus 로고    scopus 로고
    • Early abortion services in the United States: A provider survey
    • DOI 10.1016/S0010-7824(02)00512-7
    • J. Benson, K.A. Clark, A. Gerhardt, L. Randall, and S. Dudley Early abortion services in the United States: a provider survey Contraception 67 2003 287 294 (Level III) (Pubitemid 36398513)
    • (2003) Contraception , vol.67 , Issue.4 , pp. 287-294
    • Benson, J.1    Clark, K.A.2    Gerhardt, A.3    Randall, L.4    Dudley, S.5
  • 18
    • 0031864907 scopus 로고    scopus 로고
    • Effects of methotrexate on trophoblast proliferation and local immune responses
    • DOI 10.1093/humrep/13.4.1063
    • J.A. DeLoia, A.M. Stewart-Akers, and M.D. Creinin Effects of methotrexate on trophoblast proliferation and local immune responses Hum Reprod 13 1998 1063 1069 (Level III) (Pubitemid 28239221)
    • (1998) Human Reproduction , vol.13 , Issue.4 , pp. 1063-1069
    • DeLoia, J.A.1    Stewart-Akers, A.M.2    Creinin, M.D.3
  • 19
    • 0032772465 scopus 로고    scopus 로고
    • Tamoxifen compared to methotrexate when used with misoprostol for abortion
    • DOI 10.1016/S0010-7824(99)00031-1, PII S0010782499000311
    • E.R. Wiebe Tamoxifen compared to methotrexate when used with misoprostol for abortion Contraception 59 1999 265 270 (Level I) (Pubitemid 29361483)
    • (1999) Contraception , vol.59 , Issue.4 , pp. 265-270
    • Wiebe, E.R.1
  • 20
    • 0033510058 scopus 로고    scopus 로고
    • A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination
    • DOI 10.1016/S0010-7824(99)00105-5, PII S0010782499001055
    • J.K. Jain, K.R. Meckstroth, M. Park, and D.R. Mishell Jr. A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination Contraception 60 1999 353 356 (Level I) (Pubitemid 30133224)
    • (1999) Contraception , vol.60 , Issue.6 , pp. 353-356
    • Jain, J.K.1    Meckstroth, K.R.2    Park, M.3    Mishell Jr., D.R.4
  • 21
    • 79251546433 scopus 로고    scopus 로고
    • Misoprostol with or without letrozole pretreatment for termination of pregnancy: A randomized controlled trial
    • (Level I)
    • V.C. Lee, E.H. Ng, W.S. Yeung, and P.C. Ho Misoprostol with or without letrozole pretreatment for termination of pregnancy: a randomized controlled trial Obstet Gynecol 117 2011 317 323 (Level I)
    • (2011) Obstet Gynecol , vol.117 , pp. 317-323
    • Lee, V.C.1    Ng, E.H.2    Yeung, W.S.3    Ho, P.C.4
  • 22
    • 84869094892 scopus 로고    scopus 로고
    • A pilot study on the use of a 7-day course of letrozole followed by misoprostol for the termination of early pregnancy up to 63 days
    • (Level III)
    • T.W. Yeung, V.C. Lee, E.H. Ng, and P.C. Ho A pilot study on the use of a 7-day course of letrozole followed by misoprostol for the termination of early pregnancy up to 63 days Contraception 86 2012 763 769 (Level III)
    • (2012) Contraception , vol.86 , pp. 763-769
    • Yeung, T.W.1    Lee, V.C.2    Ng, E.H.3    Ho, P.C.4
  • 24
    • 0032580484 scopus 로고    scopus 로고
    • Early pregnancy termination with mifepristone and misoprostol in the United States
    • DOI 10.1056/NEJM199804303381801
    • I.M. Spitz, C.W. Bardin, L. Benton, and A. Robbins Early pregnancy termination with mifepristone and misoprostol in the United States N Engl J Med 338 1998 1241 1247 (Level II-3) (Pubitemid 28216577)
    • (1998) New England Journal of Medicine , vol.338 , Issue.18 , pp. 1241-1247
    • Spitz, I.M.1    Bardin, C.W.2    Benton, L.3    Robbins, A.4
  • 25
    • 0005662148 scopus 로고    scopus 로고
    • Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: A randomised trial. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation
    • (Level 1)
    • Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation BJOG 107 2000 524 530 (Level 1)
    • (2000) BJOG , vol.107 , pp. 524-530
  • 26
    • 0029438634 scopus 로고
    • Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol
    • [published erratum appears in Int J Fertil Menopausal Stud 1996;41:56] (Level II-3)
    • E. Aubeny, R. Peyron, C.L. Turpin, M. Renault, V. Targosz, and L. Silvestre et al. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [published erratum appears in Int J Fertil Menopausal Stud 1996;41:56] Int J Fertil Menopausal Stud 40 Suppl. 2 1995 85 91 (Level II-3)
    • (1995) Int J Fertil Menopausal Stud , vol.40 , Issue.SUPPL. 2 , pp. 85-91
    • Aubeny, E.1    Peyron, R.2    Turpin, C.L.3    Renault, M.4    Targosz, V.5    Silvestre, L.6
  • 27
    • 0033371993 scopus 로고    scopus 로고
    • Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortion
    • M.D. Creinin, and I.M. Spitz Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortion Am J Obstet Gynecol 181 1999 1419 1424 (Level III) (Pubitemid 30021887)
    • (1999) American Journal of Obstetrics and Gynecology , vol.181 , Issue.6 , pp. 1419-1424
    • Creinin, M.D.1    Spitz, I.M.2
  • 30
    • 71249118396 scopus 로고    scopus 로고
    • Mifepristone: Ten years later
    • (Level III)
    • E.A. Schaff Mifepristone: ten years later Contraception 81 2010 1 7 (Level III)
    • (2010) Contraception , vol.81 , pp. 1-7
    • Schaff, E.A.1
  • 31
    • 2942746316 scopus 로고    scopus 로고
    • A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion
    • DOI 10.1097/01.AOG.0000124271.23499.84
    • M.D. Creinin, M.C. Fox, S. Teal, A. Chen, E.A. Schaff, and L.A. Meyn A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. MOD Study Trial Group. Obstet Gynecol 103 2004 851 859 (Level I) (Pubitemid 40458983)
    • (2004) Obstetrics and Gynecology , vol.103 , Issue.5 , pp. 851-859
    • Creinin, M.D.1    Fox, M.C.2    Teal, S.3    Chen, A.4    Schaff, E.A.5    Meyn, L.A.6
  • 32
    • 58849147556 scopus 로고    scopus 로고
    • Two distinct oral routes of misoprostol in mifepristone medical abortion: A randomized controlled trial
    • (Level I)
    • B. Winikoff, I.G. Dzuba, M.D. Creinin, W.A. Crowden, A.B. Goldberg, and J. Gonzales et al. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial Obstet Gynecol 112 2008 1303 1310 (Level I)
    • (2008) Obstet Gynecol , vol.112 , pp. 1303-1310
    • Winikoff, B.1    Dzuba, I.G.2    Creinin, M.D.3    Crowden, W.A.4    Goldberg, A.B.5    Gonzales, J.6
  • 33
    • 77955821321 scopus 로고    scopus 로고
    • Misoprostol dose and route after mifepristone for early medical abortion: A randomised controlled noninferiority trial. WHO Research Group on Postovulatory Methods of Fertility Regulation.
    • (Level I)
    • H. von Hertzen, N.T. Huong, G. Piaggio, M. Bayalag, E. Cabezas, and A.H. Fang et al. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial. WHO Research Group on Postovulatory Methods of Fertility Regulation. BJOG 117 2010 1186 1196 (Level I)
    • (2010) BJOG , vol.117 , pp. 1186-1196
    • Von Hertzen, H.1    Huong, N.T.2    Piaggio, G.3    Bayalag, M.4    Cabezas, E.5    Fang, A.H.6
  • 34
    • 79955955605 scopus 로고    scopus 로고
    • Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: A systematic review
    • (Meta-analysis)
    • T.D. Ngo, M.H. Park, H. Shakur, and C. Free Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review Bull World Health Organ 89 2011 360 370 (Meta-analysis)
    • (2011) Bull World Health Organ , vol.89 , pp. 360-370
    • Ngo, T.D.1    Park, M.H.2    Shakur, H.3    Free, C.4
  • 35
    • 84875204646 scopus 로고    scopus 로고
    • Acceptability and feasibility of the use of 400mg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan
    • (Level II-3)
    • S. Raghavan, T. Tsereteli, A. Kamilov, D. Kurbanbekova, D. Yusupov, and F. Kasimova et al. Acceptability and feasibility of the use of 400mg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan Eur J Contracept Reprod Health Care 18 2013 104 111 (Level II-3)
    • (2013) Eur J Contracept Reprod Health Care , vol.18 , pp. 104-111
    • Raghavan, S.1    Tsereteli, T.2    Kamilov, A.3    Kurbanbekova, D.4    Yusupov, D.5    Kasimova, F.6
  • 36
    • 0027162337 scopus 로고
    • Comparison of medical abortion with surgical vacuum aspiration: Women's preferences and acceptability of treatment
    • R.C. Henshaw, S.A. Naji, I.T. Russell, and A.A. Templeton Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment BMJ 307 1993 714 717 (Level II-3) (Pubitemid 23275360)
    • (1993) British Medical Journal , vol.307 , Issue.6906 , pp. 714-717
    • Henshaw, R.C.1    Naji, S.A.2    Russell, I.T.3    Templeton, A.A.4
  • 37
    • 0033638774 scopus 로고    scopus 로고
    • Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion
    • (Level I)
    • M.D. Creinin Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion Contraception 62 2000 117 124 (Level I)
    • (2000) Contraception , vol.62 , pp. 117-124
    • Creinin, M.D.1
  • 38
    • 15844366622 scopus 로고    scopus 로고
    • Medical versus surgical abortion: Comparing satisfaction and potential confounders in a partly randomized study
    • DOI 10.1093/humrep/deh643
    • C. Rorbye, M. Norgaard, and L. Nilas Medical versus surgical abortion: comparing satisfaction and potential confounders in a partly randomized study Hum Reprod 20 2005 834 838 (Level II-3 (Pubitemid 40425518)
    • (2005) Human Reproduction , vol.20 , Issue.3 , pp. 834-838
    • Rorbye, C.1    Norgaard, M.2    Nilas, L.3
  • 39
    • 33745028165 scopus 로고    scopus 로고
    • Women's perceptions on medical abortion
    • DOI 10.1016/j.contraception.2006.02.012, PII S0010782406000862
    • P.C. Ho Women's perceptions on medical abortion Contraception 74 2006 11 15 (Level III) (Pubitemid 43870272)
    • (2006) Contraception , vol.74 , Issue.1 , pp. 11-15
    • Ho, P.C.1
  • 40
    • 0030897554 scopus 로고    scopus 로고
    • Vaginal misoprostol administered at home after mifepristone (RU486) for abortion
    • E.A. Schaff, L.S. Stadalius, S.H. Eisinger, and P. Franks Vaginal misoprostol administered at home after mifepristone (RU486) for abortion J Fam Pract 44 1997 353 360 (Level III) (Pubitemid 27174895)
    • (1997) Journal of Family Practice , vol.44 , Issue.4 , pp. 353-360
    • Schaff, E.A.1    Stadalius, L.S.2    Eisinger, S.H.3    Franks, P.4
  • 41
    • 0033042586 scopus 로고    scopus 로고
    • Low-dose mifepristone 200 mg and vaginal misoprostol for abortion
    • DOI 10.1016/S0010-7824(98)00150-4, PII S0010782498001504
    • E.A. Schaff, S.H. Eisinger, L.S. Stadalius, P. Franks, B.Z. Gore, and S. Poppema Low-dose mifepristone 200 mg and vaginal misoprostol for abortion Contraception 59 1999 1 6 (Level II-3) (Pubitemid 29174410)
    • (1999) Contraception , vol.59 , Issue.1 , pp. 1-6
    • Schaff, E.A.1    Eisinger, S.H.2    Stadalius, L.S.3    Franks, P.4    Gore, B.Z.5    Poppema, S.6
  • 42
    • 0036224183 scopus 로고    scopus 로고
    • Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol
    • DOI 10.1016/S0029-7844(02)01944-0, PII S0029784402019440
    • E. Wiebe, S. Dunn, E. Guilbert, F. Jacot, and L. Lugtig Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol Obstet Gynecol 99 2002 813 819 (Level I) (Pubitemid 34442460)
    • (2002) Obstetrics and Gynecology , vol.99 , Issue.5 , pp. 813-819
    • Wiebe, E.1    Dunn, S.2    Guilbert, E.3    Jacot, F.4    Lugtig, L.5
  • 44
    • 84875239820 scopus 로고    scopus 로고
    • A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation
    • (Level I)
    • J. Chai, C.Y. Wong, and P.C. Ho A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation Contraception 87 2013 480 485 (Level I)
    • (2013) Contraception , vol.87 , pp. 480-485
    • Chai, J.1    Wong, C.Y.2    Ho, P.C.3
  • 45
    • 84891027950 scopus 로고    scopus 로고
    • Medical abortion in early pregnancy
    • M. Paul, E.S. Lichtenberg, L. Borgatta, D.A. Grimes, P.G. Stubblefield, M.D. Creinin, Wiley-Blackwell Hoboken (NJ) (Level III)
    • M.D. Creinin, and K.G. Danielsson Medical abortion in early pregnancy M. Paul, E.S. Lichtenberg, L. Borgatta, D.A. Grimes, P.G. Stubblefield, M.D. Creinin, Management of unintended and abnormal pregnancy: comprehensive abortion care 2009 Wiley-Blackwell Hoboken (NJ) 111 134 (Level III)
    • (2009) Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care , pp. 111-134
    • Creinin, M.D.1    Danielsson, K.G.2
  • 47
    • 0031728395 scopus 로고    scopus 로고
    • An effective regimen for early medical abortion: A report of 2000 consecutive cases
    • P.W. Ashok, G.C. Penney, G.M. Flett, and A. Templeton An effective regimen for early medical abortion: a report of 2000 consecutive cases Hum Reprod 13 1998 2962 2965 (Level II-3) (Pubitemid 28482759)
    • (1998) Human Reproduction , vol.13 , Issue.10 , pp. 2962-2965
    • Ashok, P.W.1    Penney, G.C.2    Flett, G.M.M.3    Templeton, A.4
  • 48
    • 67349128664 scopus 로고    scopus 로고
    • Ibuprofen and paracetamol for pain relief during medical abortion: A double-blind randomized controlled study
    • (Level I)
    • A. Livshits, R. Machtinger, L.B. David, M. Spira, A. Moshe-Zahav, and D.S. Seidman Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study Fertil Steril 91 2009 1877 1880 (Level I)
    • (2009) Fertil Steril , vol.91 , pp. 1877-1880
    • Livshits, A.1    Machtinger, R.2    David, L.B.3    Spira, M.4    Moshe-Zahav, A.5    Seidman, D.S.6
  • 49
    • 0030826441 scopus 로고    scopus 로고
    • Effect of nonsteroidal anti-inflammatory drugs on the action of misoprostol in a regimen for early abortion
    • DOI 10.1016/S0010-7824(97)00120-0, PII S0010782497001200
    • M.D. Creinin, and T. Shulman Effect of nonsteroidal anti-inflammatory drugs on the action of misoprostol in a regimen for early abortion Contraception 56 1997 165 168 (Level III) (Pubitemid 27450827)
    • (1997) Contraception , vol.56 , Issue.3 , pp. 165-168
    • Creinin, M.D.1    Shulman, T.2
  • 50
    • 84883224178 scopus 로고    scopus 로고
    • Prophylactic compared with therapeutic ibuprofen analgesia in first-trimester medical abortion: A randomized controlled trial
    • (Level I)
    • E.G. Raymond, M.A. Weaver, K.S. Louie, G. Dean, L. Porsch, and E.S. Lichtenberg et al. Prophylactic compared with therapeutic ibuprofen analgesia in first-trimester medical abortion: a randomized controlled trial Obstet Gynecol 122 2013 558 564 (Level I)
    • (2013) Obstet Gynecol , vol.122 , pp. 558-564
    • Raymond, E.G.1    Weaver, M.A.2    Louie, K.S.3    Dean, G.4    Porsch, L.5    Lichtenberg, E.S.6
  • 51
    • 84870924562 scopus 로고    scopus 로고
    • First-trimester medical abortion with mifepristone 200 mg and misoprostol: A systematic review
    • (Level III)
    • E.G. Raymond, C. Shannon, M.A. Weaver, and B. Winikoff First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review Contraception 87 2013 26 37 (Level III)
    • (2013) Contraception , vol.87 , pp. 26-37
    • Raymond, E.G.1    Shannon, C.2    Weaver, M.A.3    Winikoff, B.4
  • 52
    • 51449116367 scopus 로고    scopus 로고
    • Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac
    • (Level III)
    • M.F. Reeves, A. Kudva, and M.D. Creinin Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac Contraception 78 2008 332 335 (Level III)
    • (2008) Contraception , vol.78 , pp. 332-335
    • Reeves, M.F.1    Kudva, A.2    Creinin, M.D.3
  • 53
    • 0030028245 scopus 로고    scopus 로고
    • Methotrexate and misoprostol for early abortion: A multicenter trial. I. Safety and efficacy
    • DOI 10.1016/0010-7824(96)00080-7
    • M.D. Creinin, E. Vittinghoff, L. Keder, P.D. Darney, and G. Tiller Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy. Contraception 53 1996 321 327 (Level II-3) (Pubitemid 26001013)
    • (1996) Contraception , vol.53 , Issue.6 , pp. 321-327
    • Creinin, M.D.1    Vittinghoff, E.2    Keder, L.3    Darney, P.D.4    Tiller, G.5
  • 54
    • 84872100387 scopus 로고    scopus 로고
    • Significant adverse events and outcomes after medical abortion
    • (Level III)
    • K. Cleland, M.D. Creinin, D. Nucatola, M. Nshom, and J. Trussell Significant adverse events and outcomes after medical abortion Obstet Gynecol 121 2013 166 171 (Level III)
    • (2013) Obstet Gynecol , vol.121 , pp. 166-171
    • Cleland, K.1    Creinin, M.D.2    Nucatola, D.3    Nshom, M.4    Trussell, J.5
  • 55
    • 0034928919 scopus 로고    scopus 로고
    • Curettage after mifepristone-induced abortion: Frequency, timing, and indications
    • DOI 10.1016/S0029-7844(01)01375-8, PII S0029784401013758
    • R.H. Allen, C. Westhoff, L. De Nonno, S.L. Fielding, and E.A. Schaff Curettage after mifepristone-induced abortion: frequency, timing, and indications Obstet Gynecol 98 2001 101 106 (Level III) (Pubitemid 32622772)
    • (2001) Obstetrics and Gynecology , vol.98 , Issue.1 , pp. 101-106
    • Allen, R.H.1    Westhoff, C.2    De Nonno, L.3    Fielding, S.L.4    Schaff, E.A.5
  • 56
    • 80054927981 scopus 로고    scopus 로고
    • Outcomes of medical abortion through 63 days in women with twin gestations
    • (Level III)
    • J.L. Hayes, S.L. Achilles, M.D. Creinin, and M.F. Reeves Outcomes of medical abortion through 63 days in women with twin gestations Contraception 84 2011 505 507 (Level III)
    • (2011) Contraception , vol.84 , pp. 505-507
    • Hayes, J.L.1    Achilles, S.L.2    Creinin, M.D.3    Reeves, M.F.4
  • 57
    • 0025286693 scopus 로고
    • Complications of first-trimester abortion: A report of 170,000 cases
    • E. Hakim-Elahi, H.M. Tovell, and M.S. Burnhill Complications of first-trimester abortion: a report of 170,000 cases Obstet Gynecol 76 1990 129 135 (Level II-3) (Pubitemid 20205234)
    • (1990) Obstetrics and Gynecology , vol.76 , Issue.1 , pp. 129-135
    • Hakim-Elahi, E.1    Tovell, H.M.M.2    Burnhill, M.S.3
  • 59
    • 0242606903 scopus 로고    scopus 로고
    • A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation
    • DOI 10.1093/humrep/deg475
    • O.S. Tang, C.C. Chan, E.H. Ng, S.W. Lee, and P.C. Ho A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation Hum Reprod 18 2003 2315 2318 (Level I) (Pubitemid 37427810)
    • (2003) Human Reproduction , vol.18 , Issue.11 , pp. 2315-2318
    • Tang, O.S.1    Chan, C.C.W.2    Ng, E.H.Y.3    Lee, S.W.H.4    Ho, P.C.5
  • 60
    • 84862020888 scopus 로고    scopus 로고
    • A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion
    • (Level I)
    • E. Chong, T. Tsereteli, N.N. Nguyen, and B. Winikoff A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion Contraception 86 2012 251 256 (Level I)
    • (2012) Contraception , vol.86 , pp. 251-256
    • Chong, E.1    Tsereteli, T.2    Nguyen, N.N.3    Winikoff, B.4
  • 61
    • 18044397337 scopus 로고    scopus 로고
    • Medical abortion at 9-13 weeks' gestation: A review of 1076 consecutive cases
    • DOI 10.1016/j.contraception.2004.10.015
    • H. Hamoda, P.W. Ashok, G.M. Flett, and A. Templeton Medical abortion at 9-13 weeks' gestation: a review of 1076 consecutive cases Contraception 71 2005 327 332 (Level II-3) (Pubitemid 40602308)
    • (2005) Contraception , vol.71 , Issue.5 , pp. 327-332
    • Hamoda, H.1    Ashok, P.W.2    Flett, G.M.M.3    Templeton, A.4
  • 62
    • 82255175108 scopus 로고    scopus 로고
    • Mifepristone in combination with prostaglandins for termination of 10-16 weeks' gestation: A systematic review. EBM-CONNECT Collaboration.
    • (Meta-analysis)
    • Q.J. Chen, S.P. Hou, C. Meads, Y.M. Huang, Q.Q. Hong, and H.P. Zhu et al. Mifepristone in combination with prostaglandins for termination of 10-16 weeks' gestation: a systematic review. EBM-CONNECT Collaboration. Eur J Obstet Gynecol Reprod Biol 159 2011 247 254 (Meta-analysis)
    • (2011) Eur J Obstet Gynecol Reprod Biol , vol.159 , pp. 247-254
    • Chen, Q.J.1    Hou, S.P.2    Meads, C.3    Huang, Y.M.4    Hong, Q.Q.5    Zhu, H.P.6
  • 63
    • 24344432437 scopus 로고    scopus 로고
    • A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation
    • DOI 10.1111/j.1471-0528.2005.00638.x
    • H. Hamoda, P.W. Ashok, G.M. Flett, and A. Templeton A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation BJOG 112 2005 1102 1108 (Level I) (Pubitemid 41632666)
    • (2005) BJOG: An International Journal of Obstetrics and Gynaecology , vol.112 , Issue.8 , pp. 1102-1108
    • Hamoda, H.1    Ashok, P.W.2    Flett, G.M.M.3    Templeton, A.4
  • 64
    • 84868117116 scopus 로고    scopus 로고
    • Extending outpatient medical abortion services through 70 days of gestational age
    • (Level II-3)
    • B. Winikoff, I.G. Dzuba, E. Chong, A.B. Goldberg, E.S. Lichtenberg, and C. Ball et al. Extending outpatient medical abortion services through 70 days of gestational age Obstet Gynecol 120 2012 1070 1076 (Level II-3)
    • (2012) Obstet Gynecol , vol.120 , pp. 1070-1076
    • Winikoff, B.1    Dzuba, I.G.2    Chong, E.3    Goldberg, A.B.4    Lichtenberg, E.S.5    Ball, C.6
  • 65
    • 4344627337 scopus 로고    scopus 로고
    • Infection after medical abortion: A review of the literature
    • DOI 10.1016/j.contraception.2004.04.009, PII S0010782404001283
    • C. Shannon, L.P. Brothers, N.M. Philip, and B. Winikoff Infection after medical abortion: a review of the literature Contraception 70 2004 183 190 (Level III) (Pubitemid 39119979)
    • (2004) Contraception , vol.70 , Issue.3 , pp. 183-190
    • Shannon, C.1    Brothers, L.P.2    Philip, N.M.3    Winikoff, B.4
  • 67
    • 70350574594 scopus 로고    scopus 로고
    • Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age
    • (Level III)
    • C.S. Ho, J. Bhatnagar, A.L. Cohen, J.K. Hacker, S.B. Zane, and S. Reagan et al. Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age Am J Obstet Gynecol 2009 459.e1 459.e7 (Level III)
    • (2009) Am J Obstet Gynecol
    • Ho, C.S.1    Bhatnagar, J.2    Cohen, A.L.3    Hacker, J.K.4    Zane, S.B.5    Reagan, S.6
  • 68
    • 67650485233 scopus 로고    scopus 로고
    • Rates of serious infection after changes in regimens for medical abortion
    • (Level II-3)
    • M. Fjerstad, J. Trussell, I. Sivin, E.S. Lichtenberg, and V. Cullins Rates of serious infection after changes in regimens for medical abortion N Engl J Med 361 2009 145 151 (Level II-3)
    • (2009) N Engl J Med , vol.361 , pp. 145-151
    • Fjerstad, M.1    Trussell, J.2    Sivin, I.3    Lichtenberg, E.S.4    Cullins, V.5
  • 69
    • 78650272334 scopus 로고    scopus 로고
    • Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol
    • (Level II-3)
    • H. Bracken, W. Clark, E.S. Lichtenberg, S.M. Schweikert, J. Tanenhaus, and A. Barajas et al. Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol BJOG 118 2011 17 23 (Level II-3)
    • (2011) BJOG , vol.118 , pp. 17-23
    • Bracken, H.1    Clark, W.2    Lichtenberg, E.S.3    Schweikert, S.M.4    Tanenhaus, J.5    Barajas, A.6
  • 70
    • 0027119146 scopus 로고
    • Ectopic pregnancy-United States, 1988-1989. Centers for Disease Control (CDC)
    • (Level II-3)
    • Ectopic pregnancy-United States, 1988-1989. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep 41 1992 591 594 (Level II-3)
    • (1992) MMWR Morb Mortal Wkly Rep , vol.41 , pp. 591-594
  • 71
    • 17644412300 scopus 로고    scopus 로고
    • Ectopic pregnancy rate and treatment utilization in a large managed care organization
    • DOI 10.1097/01.AOG.0000158860.26939.2d
    • S.K. Van Den Eeden, J. Shan, C. Bruce, and M. Glasser Ectopic pregnancy rate and treatment utilization in a large managed care organization Obstet Gynecol 105 2005 1052 1057 (Level II-3) (Pubitemid 40571025)
    • (2005) Obstetrics and Gynecology , vol.105 , Issue.5 , pp. 1052-1057
    • Van Den Eeden, S.K.1    Shan, J.2    Bruce, C.3    Glasser, M.4
  • 73
    • 0002692408 scopus 로고    scopus 로고
    • Surgical abortion for gestations of less than 6 weeks
    • (Level II-2)
    • J. Edwards, and M.D. Creinin Surgical abortion for gestations of less than 6 weeks Curr Probl Obstet Gynecol Fertil 20 1997 11 19 (Level II-2)
    • (1997) Curr Probl Obstet Gynecol Fertil , vol.20 , pp. 11-19
    • Edwards, J.1    Creinin, M.D.2
  • 74
    • 0026742486 scopus 로고
    • Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women
    • (Level II-3)
    • A. Ulmann, L. Silvestre, L. Chemama, Y. Rezvani, M. Renault, and C.J. Aguillaume et al. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women Acta Obstet Gynecol Scand 71 1992 278 283 (Level II-3)
    • (1992) Acta Obstet Gynecol Scand , vol.71 , pp. 278-283
    • Ulmann, A.1    Silvestre, L.2    Chemama, L.3    Rezvani, Y.4    Renault, M.5    Aguillaume, C.J.6
  • 75
    • 76049114458 scopus 로고    scopus 로고
    • A comparison of transabdominal and transvaginal ultrasonography for determination of gestational age and clinical outcomes in women undergoing early medical abortion
    • (Level II-3)
    • P.A. Lohr, M.F. Reeves, and M.D. Creinin A comparison of transabdominal and transvaginal ultrasonography for determination of gestational age and clinical outcomes in women undergoing early medical abortion Contraception 81 2010 240 244 (Level II-3)
    • (2010) Contraception , vol.81 , pp. 240-244
    • Lohr, P.A.1    Reeves, M.F.2    Creinin, M.D.3
  • 77
    • 0642371013 scopus 로고    scopus 로고
    • Medical abortion in family practice: A case series
    • (Level III)
    • L. Prine, R. Lesnewski, N. Berley, and M. Gold Medical abortion in family practice: a case series J Am Board Fam Pract 16 2003 290 295 (Level III)
    • (2003) J Am Board Fam Pract , vol.16 , pp. 290-295
    • Prine, L.1    Lesnewski, R.2    Berley, N.3    Gold, M.4
  • 79
    • 4644372600 scopus 로고    scopus 로고
    • Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion
    • DOI 10.1016/j.contraception.2004.04.005, PII S0010782404001143
    • B. Rossi, M.D. Creinin, and L.A. Meyn Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion Contraception 70 2004 313 317 (Level II-3) (Pubitemid 39286767)
    • (2004) Contraception , vol.70 , Issue.4 , pp. 313-317
    • Rossi, B.1    Creinin, M.D.2    Meyn, L.A.3
  • 81
    • 79955938270 scopus 로고    scopus 로고
    • Alternatives to ultrasound for follow-up after medication abortion: A systematic review
    • (Level III)
    • D. Grossman, and K. Grindlay Alternatives to ultrasound for follow-up after medication abortion: a systematic review Contraception 83 2011 504 510 (Level III)
    • (2011) Contraception , vol.83 , pp. 504-510
    • Grossman, D.1    Grindlay, K.2
  • 82
    • 67650267741 scopus 로고    scopus 로고
    • Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention
    • (Level III)
    • M.F. Reeves, M.C. Fox, P.A. Lohr, and M.D. Creinin Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention Ultrasound Obstet Gynecol 34 2009 104 109 (Level III)
    • (2009) Ultrasound Obstet Gynecol , vol.34 , pp. 104-109
    • Reeves, M.F.1    Fox, M.C.2    Lohr, P.A.3    Creinin, M.D.4
  • 84
    • 84862027967 scopus 로고    scopus 로고
    • Telephone follow-up and self-performed urine pregnancy testing after early medical abortion: A service evaluation
    • (Level II-3)
    • S.T. Cameron, A. Glasier, H. Dewart, A. Johnstone, and A. Burnside Telephone follow-up and self-performed urine pregnancy testing after early medical abortion: a service evaluation Contraception 86 2012 67 73 (Level II-3)
    • (2012) Contraception , vol.86 , pp. 67-73
    • Cameron, S.T.1    Glasier, A.2    Dewart, H.3    Johnstone, A.4    Burnside, A.5
  • 85
    • 34047255922 scopus 로고    scopus 로고
    • Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited
    • DOI 10.1016/j.contraception.2007.01.021, PII S0010782407000820
    • E.M. Godfrey, A. Anderson, S.L. Fielding, L. Meyn, and M.D. Creinin Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited Contraception 75 2007 378 382 (Level II-3) (Pubitemid 46551079)
    • (2007) Contraception , vol.75 , Issue.5 , pp. 378-382
    • Godfrey, E.M.1    Anderson, A.2    Fielding, S.L.3    Meyn, L.4    Creinin, M.D.5
  • 86
    • 34447542532 scopus 로고    scopus 로고
    • Accuracy of a semi-quantitative urine pregnancy test compared to serum beta-hCG measurement: A possible screening tool for ongoing pregnancy after medication abortion
    • DOI 10.1016/j.contraception.2007.04.008, PII S0010782407001941
    • D. Grossman, K. Berdichevsky, F. Larrea, and J. Beltran Accuracy of a semi-quantitative urine pregnancy test compared to serum beta-hCG measurement: a possible screening tool for ongoing pregnancy after medication abortion Contraception 76 2007 101 104 (Level II-3) (Pubitemid 47080983)
    • (2007) Contraception , vol.76 , Issue.2 , pp. 101-104
    • Grossman, D.1    Berdichevsky, K.2    Larrea, F.3    Beltran, J.4
  • 87
    • 84876252467 scopus 로고    scopus 로고
    • Medical abortion follow-up with serum human chorionic gonadotropin compared with ultrasonography: A randomized controlled trial
    • (Level I)
    • I. Dayananda, R. Maurer, J. Fortin, and A.B. Goldberg Medical abortion follow-up with serum human chorionic gonadotropin compared with ultrasonography: a randomized controlled trial Obstet Gynecol 121 2013 607 613 (Level I)
    • (2013) Obstet Gynecol , vol.121 , pp. 607-613
    • Dayananda, I.1    Maurer, R.2    Fortin, J.3    Goldberg, A.B.4
  • 88
    • 84858338547 scopus 로고    scopus 로고
    • Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment
    • (Level II-3)
    • E.L. Horning, B.A. Chen, L.A. Meyn, and M.D. Creinin Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment Contraception 85 2012 402 407 (Level II-3)
    • (2012) Contraception , vol.85 , pp. 402-407
    • Horning, E.L.1    Chen, B.A.2    Meyn, L.A.3    Creinin, M.D.4
  • 89
    • 84869097620 scopus 로고    scopus 로고
    • Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study
    • (Level II-3)
    • J. Blum, T. Shochet, K. Lynd, E.S. Lichtenberg, D. Fischer, and M. Arnesen et al. Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study Contraception 86 2012 757 762 (Level II-3)
    • (2012) Contraception , vol.86 , pp. 757-762
    • Blum, J.1    Shochet, T.2    Lynd, K.3    Lichtenberg, E.S.4    Fischer, D.5    Arnesen, M.6
  • 90
    • 0034684142 scopus 로고    scopus 로고
    • Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial [published erratum appears in JAMA 2000;284:2597]
    • (Level I)
    • E.A. Schaff, S.L. Fielding, C. Westhoff, C. Ellertson, S.H. Eisinger, and L.S. Stadalius et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial [published erratum appears in JAMA 2000;284:2597] JAMA 284 2000 1948 1953 (Level I)
    • (2000) JAMA , vol.284 , pp. 1948-1953
    • Schaff, E.A.1    Fielding, S.L.2    Westhoff, C.3    Ellertson, C.4    Eisinger, S.H.5    Stadalius, L.S.6
  • 91
    • 27644535840 scopus 로고    scopus 로고
    • Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone
    • DOI 10.1016/j.ejogrb.2005.02.019, PII S0301211505000795
    • C. Arvidsson, M. Hellborg, and K. Gemzell-Danielsson Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone Eur J Obstet Gynecol Reprod Biol 123 2005 87 91 (Level I) (Pubitemid 41563100)
    • (2005) European Journal of Obstetrics Gynecology and Reproductive Biology , vol.123 , Issue.1 , pp. 87-91
    • Arvidsson, C.1    Hellborg, M.2    Gemzell-Danielsson, K.3
  • 92
    • 0033968228 scopus 로고    scopus 로고
    • Misoprostol's effect on uterine arterial blood flow and fetal heart rate in early pregnancy
    • DOI 10.1016/S0029-7844(99)00472-X, PII S002978449900472X
    • S.K. Yip, A.O. Tse, C.J. Haines, and T.K. Chung Misoprostol's effect on uterine arterial blood flow and fetal heart rate in early pregnancy Obstet Gynecol 95 2000 232 235 (Level III) (Pubitemid 30045645)
    • (2000) Obstetrics and Gynecology , vol.95 , Issue.2 , pp. 232-235
    • Yip, S.-K.1    Tse, A.O.-K.2    Haines, C.J.3    Chung, T.K.-H.4
  • 93
    • 0025735505 scopus 로고
    • Misoprostol and congenital malformations
    • (Level III)
    • W. Fonseca, A.J. Alencar, F.S. Mota, and H.L. Coelho Misoprostol and congenital malformations Lancet 338 1991 56 (Level III)
    • (1991) Lancet , vol.338 , pp. 56
    • Fonseca, W.1    Alencar, A.J.2    Mota, F.S.3    Coelho, H.L.4
  • 97
    • 0030936566 scopus 로고    scopus 로고
    • Abortion induced with methotrexate and misoprostol: A comparison of various protocols
    • DOI 10.1016/S0010-7824(97)00021-8, PII S0010782497000218
    • E.R. Wiebe Abortion induced with methotrexate and misoprostol: a comparison of various protocols Contraception 55 1997 159 163 (Level II-3) (Pubitemid 27180391)
    • (1997) Contraception , vol.55 , Issue.3 , pp. 159-163
    • Wiebe, E.R.1
  • 98
    • 84880922628 scopus 로고    scopus 로고
    • New anomalies due to methotrexate and misoprostol exposure in early pregnancy
    • (Level III)
    • K. MacDonald, W.V. Norman, and O. Popescu New anomalies due to methotrexate and misoprostol exposure in early pregnancy Int J Gynaecol Obstet 122 2013 267 268 (Level III)
    • (2013) Int J Gynaecol Obstet , vol.122 , pp. 267-268
    • Macdonald, K.1    Norman, W.V.2    Popescu, O.3
  • 99
    • 0033038045 scopus 로고    scopus 로고
    • Conception rates after abortion with methotrexate and misoprostol
    • (Level III)
    • M.D. Creinin Conception rates after abortion with methotrexate and misoprostol Int J Gynaecol Obstet 65 1999 183 188 (Level III)
    • (1999) Int J Gynaecol Obstet , vol.65 , pp. 183-188
    • Creinin, M.D.1
  • 102
    • 84881259457 scopus 로고    scopus 로고
    • Changes in association between previous therapeutic abortion and preterm birth in Scotland, 1980 to 2008: A historical cohort study
    • (Level II-3)
    • C. Oliver-Williams, M. Fleming, K. Monteath, A.M. Wood, and G.C. Smith Changes in association between previous therapeutic abortion and preterm birth in Scotland, 1980 to 2008: a historical cohort study PLoS Med 10 2013 e1001481 (Level II-3)
    • (2013) PLoS Med , vol.10 , pp. 1001481
    • Oliver-Williams, C.1    Fleming, M.2    Monteath, K.3    Wood, A.M.4    Smith, G.C.5
  • 103
    • 66449109221 scopus 로고    scopus 로고
    • Non-physician clinicians can safely provide first trimester medical abortion
    • (Level III)
    • J. Yarnall, Y. Swica, and B. Winikoff Non-physician clinicians can safely provide first trimester medical abortion Reprod Health Matters 17 2009 61 69 (Level III)
    • (2009) Reprod Health Matters , vol.17 , pp. 61-69
    • Yarnall, J.1    Swica, Y.2    Winikoff, B.3
  • 104
    • 79953275741 scopus 로고    scopus 로고
    • Can midlevel health-care providers administer early medical abortion as safely and effectively as doctors? A randomised controlled equivalence trial in Nepal
    • (Level I)
    • I.K. Warriner, D. Wang, N.T. Huong, K. Thapa, A. Tamang, and I. Shah et al. Can midlevel health-care providers administer early medical abortion as safely and effectively as doctors? A randomised controlled equivalence trial in Nepal Lancet 377 2011 1155 1161 (Level I)
    • (2011) Lancet , vol.377 , pp. 1155-1161
    • Warriner, I.K.1    Wang, D.2    Huong, N.T.3    Thapa, K.4    Tamang, A.5    Shah, I.6
  • 105
    • 79961071838 scopus 로고    scopus 로고
    • Effectiveness and acceptability of medical abortion provided through telemedicine
    • (Level II-3)
    • D. Grossman, K. Grindlay, T. Buchacker, K. Lane, and K. Blanchard Effectiveness and acceptability of medical abortion provided through telemedicine Obstet Gynecol 118 2011 296 303 (Level II-3)
    • (2011) Obstet Gynecol , vol.118 , pp. 296-303
    • Grossman, D.1    Grindlay, K.2    Buchacker, T.3    Lane, K.4    Blanchard, K.5
  • 106
    • 84872530062 scopus 로고    scopus 로고
    • Changes in service delivery patterns after introduction of telemedicine provision of medical abortion in Iowa
    • (Level II-3)
    • D.A. Grossman, K. Grindlay, T. Buchacker, J.E. Potter, and C.P. Schmertmann Changes in service delivery patterns after introduction of telemedicine provision of medical abortion in Iowa Am J Public Health 103 2013 73 78 (Level II-3)
    • (2013) Am J Public Health , vol.103 , pp. 73-78
    • Grossman, D.A.1    Grindlay, K.2    Buchacker, T.3    Potter, J.E.4    Schmertmann, C.P.5
  • 107
    • 78650750259 scopus 로고    scopus 로고
    • U. S. Medical Eligibility Criteria for Contraceptive Use, 2010. Centers for Disease Control and Prevention (CDC)
    • (Level III)
    • U. S. Medical Eligibility Criteria for Contraceptive Use, 2010. Centers for Disease Control and Prevention (CDC) MMWR Recomm Rep 59 RR-4 2010 1 86 (Level III)
    • (2010) MMWR Recomm Rep , vol.59 , Issue.RR-4 , pp. 1-86
  • 108
    • 33744983070 scopus 로고    scopus 로고
    • Contraception after medical abortion
    • DOI 10.1016/j.contraception.2006.03.006, PII S0010782406000850
    • S. Mittal Contraception after medical abortion Contraception 74 2006 56 60 (Level III) (Pubitemid 43866058)
    • (2006) Contraception , vol.74 , Issue.1 , pp. 56-60
    • Mittal, S.1
  • 109
    • 84887208524 scopus 로고    scopus 로고
    • Understanding and using the U.S. Selected practice recommendations for contraceptive use, 2013. Committee Opinion No. 577. American College of Obstetricians and Gynecologists
    • (Level III)
    • Understanding and using the U.S. selected practice recommendations for contraceptive use, 2013. Committee Opinion No. 577. American College of Obstetricians and Gynecologists Obstet Gynecol 122 2013 1132 1133 (Level III)
    • (2013) Obstet Gynecol , vol.122 , pp. 1132-1133
  • 110
    • 80052141380 scopus 로고    scopus 로고
    • Timing of copper intrauterine device insertion after medical abortion: A randomized controlled trial
    • (Level I)
    • N. Shimoni, A. Davis, M.E. Ramos, L. Rosario, and C. Westhoff Timing of copper intrauterine device insertion after medical abortion: a randomized controlled trial Obstet Gynecol 118 2011 623 628 (Level I)
    • (2011) Obstet Gynecol , vol.118 , pp. 623-628
    • Shimoni, N.1    Davis, A.2    Ramos, M.E.3    Rosario, L.4    Westhoff, C.5
  • 111
    • 84869136256 scopus 로고    scopus 로고
    • Early versus delayed insertion of intrauterine contraception after medical abortion - A randomized controlled trial
    • (Level I)
    • I. Saav, O. Stephansson, and K. Gemzell-Danielsson Early versus delayed insertion of intrauterine contraception after medical abortion - a randomized controlled trial PLoS One 7 2012 e48948 (Level I)
    • (2012) PLoS One , vol.7 , pp. 48948
    • Saav, I.1    Stephansson, O.2    Gemzell-Danielsson, K.3
  • 112
    • 79958183053 scopus 로고    scopus 로고
    • Immediate versus delayed IUD insertion after uterine aspiration. Post-Aspiration IUD Randomization (PAIR) Study Trial Group
    • (Level I)
    • P.H. Bednarek, M.D. Creinin, M.F. Reeves, C. Cwiak, E. Espey, and J.T. Jensen Immediate versus delayed IUD insertion after uterine aspiration. Post-Aspiration IUD Randomization (PAIR) Study Trial Group N Engl J Med 364 2011 2208 2217 (Level I)
    • (2011) N Engl J Med , vol.364 , pp. 2208-2217
    • Bednarek, P.H.1    Creinin, M.D.2    Reeves, M.F.3    Cwiak, C.4    Espey, E.5    Jensen, J.T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.